WO2012017075A1

WO2012017075A1 - Packaging comprising a drug-carrier element which can be separated from the packaging and outer packaging

Info

Publication number: WO2012017075A1
Application number: PCT/EP2011/063525
Authority: WO
Inventors: Claudia Hauser
Original assignee: Hochschule Für Technik Und Wirtschaft Berlin
Priority date: 2010-08-06
Filing date: 2011-08-05
Publication date: 2012-02-09
Also published as: DE102010033982A1

Abstract

The invention relates to a packaging and to an associated outer packaging (100, 200, 300) for a drug (M), having a base element (10, 20, 30) which protects the drug (M) from outside influences when the packaging is in the unopened state. According to the invention, the base element (10, 20, 30) has at least one carrier element (11, 21, 31) which carries the drug (M) and can be separated from the base element (10, 20, 30) of the packaging, whereby the carrier element (11, 21, 31) is used as an administration element or application element for the drug (M).

Description

Packaging with a carrier element which can be separated from the packaging

for a drug as well as outer packaging

The invention relates to a packaging for a medicament, which has a base element which protects the medicament from external influences in the unopened state of the packaging, as well as an associated outer packaging for the packaging of the medicament.

Medicines must be packed sterile and taken or administered as sterile as possible. Their intake is sometimes subject to strict time conditions. When taking or administering tablets, they usually have to be removed first from an outer packaging and then removed in the most common packaging form a blister. For this you have in conventional blisters the blister tray, in which the tablet is, press, causing the tablet breaks through the trough closing aluminum layer and falls out. In most cases, the tablet is dropped into the palm of its hand or into a vessel, from which it is then taken up, taken to the mouth and ingested or administered. It can also happen that one misses completely when expressing the tablet, the hand or the vessel into which the tablet is to be placed, whereby it may fall to the floor and / or be lost. The more contact a drug has with other objects (hands, tools, or other objects), the greater the risk that the drug or substance will come into contact with germs. A lost tablet and thus an interruption in the systematic intake of a preparation can affect its overall negative effect. Surveys on taking medication or administering medication have shown:

First, the respondents most often expressed difficulties with the complicated and confusing descriptions of the leaflets and the difficulty in taking tablets from the blister packs. In particular, the removal from blister packs often leads to the tablet jumping away or the individual cases are too small or too tightly welded. In addition, more striking information such as expiration date and drug names on the blister missing. Secondly, it is considered annoying that blister, box and leaflet are independent of each other and thus can be reversed. Thus, a double information is always necessary, once on the outer packaging and once on the actual packaging of the blister. The third most common problem is the informational language on the packaging. The information on the packaging is rated as insufficient and not very transparent. Respondents want information structured according to importance. Most of the writing is much too small and can be read badly or not at all. Respondents want clear names of the area of application (hypertension, diarrhea etc.).

Fourthly, one interesting finding from the survey is that one third of the respondents are on-the-go as needed. This mainly affects painkillers. For the transport of medicines in the handbag, the respondents want a packaging suitable for everyday use and outer packaging, which also somehow, for example, is colorful. In particular, for small drug units (Herpessalbe, o. Ä.) Wrapping and packaging is also desired, which is easily found in the bag and not lost so quickly.

DE 20 2005 014 482 U1 proposes to improve the intake or administration of a drug before a package for tablets or dosed drops, the shape of a safe and hygienic oral administration or administering allows. The tablet package consists of a spoon-like support element and a closing, one-sided applied protective film. Formally, the carrier element in its longitudinal orientation roughly divided into two halves, it has at the front end a shell-like depression in which the tablet is or the metered liquid is located and at the rear end of a surface as a handle. The trough is closed sterile with a tear-resistant foil. This film is merely glued to the carrier element directly around the trough, but also extends in its extension over the gripping surface. Here the non-glued foil forms a tab. The adhesion of the film can be easily solved by pulling on the tab. To open, hold the package so that the bowl-like trough is arched down, from which now the film is completely removed by peeling. The tablets or the finished dosed drops are still in the trough and can - as with a spoon - directly be taken or administered without coming into contact with other objects. The disadvantage of this known from the prior art packaging is that for hygienic taking of the drug, a part of the package is used as a spoon, which does not appear sufficiently hygienic, since the surface of the serving as a spoon package, when they take to take the drug for Mouth is guided, if necessary, but comes into contact with the mouth.

Therefore, based on the problems analyzed by the survey and based on the current state of the art, the object of the invention is to provide an easily manageable, in particular easy-to-open, packaging for medicaments, or their administration by persons using the medicament by third sure, in the right dosage, especially without direct contact of the drug with other objects, especially hygienic. In conjunction with the features of the preamble of claim 1, which knows a package for a drug having a base member which protects the drug in the unopened state of the package from external influences, the object is achieved by the features of the characterizing part of claim 1 thereby solved that the base member has at least one support member which carries the drug which is separable from the base member of the package, whereby the support member serves as ingestion or administration element for the drug.

For drugs in solid tablet form, the following two different embodiments were developed.

First embodiment of the package, the so-called "fixed tablet" with associated outer packaging as a so-called "Kalenderblister". In a preferred embodiment, this first embodiment of the packaging is characterized in that a first base element is a blister whose at least one depression is closed by a carrier element, wherein the carrier element has two layers and has a first, outer carrier layer and a second, inner carrier layer. the Drug is fixed on the directed to the trough of the first base member inside of the second, inner carrier layer by means of an adhesive.

In a preferred embodiment of the invention, the second, inner carrier layer is hermetically fixed in the closed state of the trough as a closure element on the edge of the trough, preferably glued and the first, outer carrier layer is by forming a fold substantially parallel to the second, inner carrier layer as the opening element serving the trough, arranged exposed.

According to the invention, it is further provided to use the upper side of the first and / or second carrier layer as the labeling field.

The embodiment of the first embodiment advantageously makes it possible for the first two-layer carrier element in the withdrawn state from the first base element, as a receiving or administering element for the medicament, to form a spoon, which holds a holding region formed by the first, outer carrier layer and one through the second , Inner carrier layer has formed application area.

The carrier layers of the carrier element are preferably formed from a film, in particular a transparent film.

The first embodiment includes an outer packaging which ensures that the packaging can be stored protected in a frame-like container, a kind of folding box and used as a "calendar blister." The first outer packaging and its advantages are explained in more detail in the following description.

Second embodiment, the so-called "fixed tablet" as a so-called "tablet dispenser" with associated outer packaging.

In a preferred embodiment, this second embodiment of the packaging is characterized in that a second base element is a tube into which a carrier element can be plugged at one end and the tube is closed airtight at both ends, the medicament being fixed on the carrier element by means of an adhesive.

In a preferred embodiment of the second embodiment, it is advantageously possible for the carrier element to be pulled out of the second base element Condition, as a receiving or administering element for the drug forms a spoon having a holding portion formed by a handle and an application area formed by an end portion of the support member.

According to the invention it is provided that the handle of the spoon on one or both sides serves as a labeling field.

In a preferred development of the second embodiment, a hanging element can be plugged into the tube at the other end of the carrier element, so that a calendar-like tablet dispenser in the manner of a tear-off calendar is formed by arranging a plurality of base and carrier elements by connecting a plurality of hanging elements one above the other.

In a preferred embodiment of the invention, the hose of the base element is formed from a film, in particular a transparent film.

The second embodiment also includes an outer packaging, which ensures that the packaging is arranged protected in a container, in particular in a prismatic container. The second outer packaging and its advantages will be explained in more detail in the following description.

For a drug in ointment or powder form, a third embodiment was developed.

Third embodiment, the so-called "fixed powder" or the so-called "fixed ointment" on a so-called application rod or application stick with associated outer packaging.

This third embodiment of the package is characterized in a preferred embodiment in that a third base element is a pocket, in particular a foil pocket, which is arranged on a bottom and / or cover flap, a flap folder into which the carrier element is pluggable, wherein the medicament is fixed on a single-sided cushion, designed as a support member rod-shaped element, a rod or a spatula. The embodiment of the third embodiment advantageously makes it possible for the carrier element to be designed as a receiving or administering element for the medicament, as a rod or spatula, in the state pulled out of the second base element, comprising a holding region formed by a grip piece and one of an end piece having formed application area.

According to the invention it is further provided to use the handle of the support element on one or both sides as a labeling field.

The third embodiment also includes an outer packaging which ensures that the packaging can be stored protected in a banderole-like container. The third outer packaging and its advantages will be explained in more detail in the following description.

Further preferred embodiments of the three embodiments of the invention will become apparent from the description and from the remaining features mentioned in the subclaims.

The invention will be explained below in embodiments with reference to the accompanying drawings. FIG. 1A is a perspective view of a first outer packaging for a

Packaging according to the first embodiment (first packaging) for a medicament;

Figure 1 B is a perspective view of the opened outer packaging with a first, upper packaging;

Figure 1 C is a perspective view of the open and calendar-like, unfolded outer packaging with a first, lower packaging; Figure 1 D other perspective view of Figure 1 C;

Figure 1 E is an enlarged perspective view of the carrier element of the first package; Figure 1 F is a schematic representation of the first package as a hanging calendar in a hanging position of the unfolded outside (left) and the unfolded inside (right) of the outer packaging;

Figures 1 G, 1 H each show a perspective view of the removal steps associated with the carrier element drug from the first

Packaging;

FIGS. 11, 1J each show a perspective view of the intake steps of the medicament associated with the first carrier element;

Figure 2A is a perspective view of a second outer packaging for a

Packaging according to the second embodiment (second packaging) for a medicament; Figure 2B is a perspective view of the second outer packaging in a first hanging position;

Figure 2C is a perspective view of the second outer packaging in a second hanging position;

FIG. 2D shows a perspective side view of the second packaging;

Figure 2E is a front perspective view of the second package; Figure 2F is a rear perspective view of the second package;

Figure 2G is a schematic representation of the second packaging from the side as

Hanging calendar in a hanging position; Figure 2H is a schematic representation of the second packaging, the front

(left) and the back (right) FIGS. 21, 2J are perspective views of the removal steps of a medicament associated with the second carrier element from the second packaging;

2K each show a perspective view of the intake steps of the medicament connected to the second carrier element;

Figure 3A is a perspective view of a package in a third

Embodiment (third package) for a medicament (left) Figure 3B is a perspective view of the inside of the third package;

Figure 3C is a schematic representation of the third package, from the open and unopened front (center) and the inside (right) and the application of the drug (left);

FIG. 3D perspective views of the removal steps of a medicament associated with a third carrier element from the third packaging; FIG. 3E shows an outer packaging belonging to the third packaging.

First embodiment of the package, the so-called "fixed tablet" with associated outer packaging as a so-called "Kalenderblister". 1A shows a perspective view of a first outer packaging 100 for a first packaging for a medicament M. The first outer packaging 100 has a cover flap 101, a frame-like container 102, a front cover flap 103 with a closure and hanging element 104 and a rear flap 105 , A bottom flap 106 and a front flap 107, which also belong to the first outer package 100 in the manner of a folding box, are shown for the first time in FIGS. 1B and 1C. The flaps are arranged on each other unspecified folds movable. In Figure 1 B, the first outer package 100 is shown in the open state. The closure and hanging element 104 is opened by pulling the locking tab out of a slot 110 of the first outer packaging 100. As a result, a first, upper package 10, 10-1 becomes visible. In addition, a labeling field 107-1, which is executed on the outside of the front flap 107 of the outer package 100, visible. On the label field 107-1, the days of the week - Monday to Sunday - are listed in short names, with small arrows to the individual blister troughs of the first, upper packaging show, which are arranged in three rows in the embodiment. In FIG. 1C, the first outer packaging 100 is opened further and unfolded like a calendar. On an inner side of the cover flap 101, an inner flap 108 is visible. Furthermore, it is visible that the rear flap 105 and the front flap 107 are formed laterally of the bottom flap 106. In this calendar-like opened unfolded first outer packaging 100, unlike in FIG. 1B, the rear side of the frame-like container 102 is visible, in which a first, lower packaging 10, 10-2 is arranged parallel to the first, upper packaging (FIG. 1B) , The first, upper and lower packages 10, 10-1, 10-2 are each a first or second blister, the troughs of which are closed by a carrier element 11. In Figure 1 C is denoted by the reference numeral 107-1, that also on the inside of the front flap 107, a labeling field 107-1 is executed, which also marks the days of the week - Monday to Sunday - with associated pointing in the direction of the blister troughs arrows.

In FIG. 1D, it can be seen in particular that an instruction leaflet 109 is arranged between the cover flap 101 and the inner flap 108. By this embodiment shown in the figures, the first package with the outer package 100 advantageously forms a unit in the inseparable from the outer packaging 100 connected to a leaflet 109 can be arranged.

The invention is characterized in that on the first base member 10, at least one support member 1 1 is arranged, which carries the drug M, which is separable from the first base member 10 of the first package, whereby the support member 11 as ingestion or administration element for the Drug M is used. This first support element 1 1 is shown in Figure 1 D by way of example in the upper row, seen in a third position from the right, in the form of a first outer support layer 1 1-1 folded up and shown in Figure 1 E in an enlarged perspective view, wherein the first, outer carrier layer 1 1-1 is here arranged substantially parallel to a second, inner carrier layer 1 1-2 lying on a trough of the first base element 10.

The second, inner carrier layer 1 1-2 is respectively disposed on the trough of the first base member 10 and closes or seals the trough to protect the drug M against external influences airtight. The second, inner carrier layer 1 1- 2 can be glued, welded or otherwise applied airtight on the trough. Each of the wells is thus provided with a two-layer support element 1 1, wherein in the exemplary embodiment on the first, outer carrier layer 1 1-1 preferably pictograms are provided, the morning time (upper row), noon (middle row) and evening (lower Symbolize). The use of the pictogram language is for the understanding of the user, especially for the elderly of particular advantage.

Using the same reference numerals for the same components, Figure 1 F shows a schematic representation of the first packaging as a hanging calendar in a hanging position. On the left side of Figure 1, the hanging calendar is suspended by means of the closure and hanging element 104 so that the outside of the first outer packaging 100 is visible. This becomes clear, since in this illustration the inner flap 108, which is provided inside the first outer packaging 100 for the arrangement of the leaflet 109, is not visible. In this arrangement, the first, upper package 10, 10-1 is visible, which is arranged in accordance with Figure 1A or Figure 1 B in the initial state in the first outer package 100 above. In contrast, Figure 1 F shows on the right side of the hanging calendar, which is suspended by means of the closure and hanging element 104 so that the inside of the first outer package 100 is visible. As a result, the inner flap 108, which is otherwise inside the first outer packaging 100, visible. If the first outer packaging 100 with the first, lower packaging 10, 10-2 lying therein is suspended so that the inner side of the first outer packaging 100 is visible, the first, lower packaging 10, 10-2 thus becomes accessible to the user. The invention provides that the front flap 107 has on its inside and on its outside a labeling field 107-1. On the left side of FIG. 1F, the outer labeling field 107-1 is visible, which in FIG. 1B is in the front region the first outer packaging 100 is located. On the right side of Figure 1 F, the inside label panel 107-1 is visible.

It can also be seen from the schematic illustration that the wells of the first and second blisters 10, 10-1, 10-2, which serve as basic elements of the first packaging, each in three rows according to the intake times, morning, noon, evening and clear in the 7-day rhythm are arranged. When arranging two blisters 10,

10-1, 10-2 can thus be secured within a first outer packaging 100 with medication M for two weeks. The use as a turn-hanging calendar also has the advantage that the removal of the drugs M, when the first outer packaging 100 is suspended over the closure and hanging element 104, by means of one-handed operation is possible.

The removal steps of the medicament M connected to the carrier element 11 are discussed in perspective views of FIGS. 1G and 1H. The use of the reference numbers is unchanged. The removal takes place by way of example from the first, upper packaging, the first blister 10, 10-1. The removal of a tablet is an example on a Friday, in the morning. The user grasps the first, outer carrier layer 1 1-1 and pulls on the carrier element 1 1, whereby the carrier element 1 1, which is folded in two layers in its unopened starting position by a fold 11 -3, punctured and unfolded, whereby the second , inner carrier layer

1 1- 2 releases from the edge of the trough of the first blister 10, 10-1. On the inside of the first blister 10, 10-1, the tablet is fixed by means of a glue K harmless to humans. Due to the dead weight of the tablet, the second, inner carrier layer 1 1-2 1-2 folds after the complete removal of the support element 1 1 on the finger, in the embodiment of the thumb of the removal hand and can be safely performed to the mouth of the user.

The administration or administration of the medicament M connected to the first carrier element 11 can be seen in perspective views of FIGS. 11 and 1J. The inside of the second, inner carrier layer 1-2 is guided to the mouth, so that the user simply removes the medicine M with the lips and / or tongue from the inside of the second, inner carrier layer 1-2 and is particularly hygienic can take. In this case, the drug M does not come into contact with other objects.

The first outer packaging 100 with the blisters 10, 10-1, 10-2 arranged therein as the first packaging with the two-layer carrier element 11 according to the invention is very compact and thus also suitable for carrying along. Therefore, the use is especially for life-saving drugs that are taken daily and regularly, so in particular for cardiovascular and chronically ill patients of particular advantage. For the preferred use of the first outer packaging 1 10 and the first package diseases such as ADHD, multiple sclerosis, heart disease and AIDS are called. The list of possible uses of the first package and first outer package 100 is not exhaustive.

Figure 2A shows in several pictures (upper figures, left in a front view and center, right in a rear view and lower pictures below, left in a view on the back or bottom, right on the front) perspective views of a second outer packaging 200 for a second Package for a drug M. The second outer package 200 is a prismatic container 202, which has on one of its surfaces a cover flap 201 which is foldable over a fold 211 away from the shell of the prismatic container 202. The cover flap 201 has, analogously to the first outer packaging 100, a closure and hanging element 204. This closure and hanger member 204 may be placed over the tip of the prismatic container 202 and inserted into a slot 210 on the other side (back side) of the tip. The lid flap 201 serves as a closure element 204 for the prismatic container 202 and as a hanging element 204 by means of which the container 202 can be hung on a wall or the like, as shown in FIGS. 2B and 2C in perspective views. The attachment of the prismatic container 202 to a wall or the like is done, for example, according to Figure 2B in a first alternative with the inside of the lid flap 202 directed towards the wall, whereby the container 202 then hangs substantially closed against the wall. In a second alternative, the attachment of the prismatic container 202, according to FIG. 2C, with the outside of the cover flap 202 is directed towards the wall, whereby the Container 202 can then hang substantially open on the wall. The removal of the second packaging from the second outer packaging 200 is thereby possible at any time, with the first alternative, on the other hand, having the advantage that the second packaging is better protected against light and other influences. In the following figures 2D to 2J, the second package in the manner of a tablet dispenser is shown in various perspective views, wherein the second package is initially at least a second base member 20, in the form of a hose open on both sides. In the exemplary embodiment, this hose, which is open on both sides, is made of a transparent blister-like film. In the second base member 20, a support member 21 is plugged at least at one end and the base member 20 is closed at both ends. The film of the tube is at least on the side of the support element 21 end turned inside. By pulling on the carrier element 21, the gluing / sealing / welding of the folded region on the carrier element 21 provided as closure is easily released again from the carrier element 21, whereby the tube for removal of the carrier element 21 is opened on one side. On the support member 21, a drug M is fixed by means of a human harmless adhesive K. If a plurality of such tubular base elements 20 connected to the inserted support member 21 via the second base member 20 with each other, there is already a tablet dispenser, which simplifies the administration or administration of a drug M. If the second carrier element 21 is pulled out of the second base element 20, it serves as a receiving and administering element for the drug M. The carrier element 21 is designed as a spoon, which has a handle 21-1 as a holding area and an end portion 21-2 as an application area.

In FIGS. 2D to 2J, however, the tablet dispenser also has an additional feature, which consists in the fact that a hanging element 23 is inserted into the tube-like base element 20 at the other end of the carrier element 21. In the perspective view of FIG. 2D, by way of example, a plurality of second base elements 20 with carrier elements 21 arranged therein are preferably connected to one another via the upper edge of the hanging element 23.

FIG. 2E shows a perspective front view of the film tube 22 used as the second base element 20 and the carrier element 21 arranged therein, which lies with its end piece 21-2 inside the film tube 22 in an enlarged view Presentation. The drug M is protected on the end piece 21-2, since the film tube 22 is hermetically sealed in the lower region of the hanging element 23 and in the central region of the support element 21, preferably welded. The drug M is thus protected from external environmental influences. On the front side of the handle 21-1 there is a labeling field 21-3 for the day of the week, which at the same time by means of an arrow shows in which direction the carrier element 21 has to be pulled in order to pull the medicament M out of the base element 20. FIG. 2F shows the carrier element 21 from the rear side, which shows that a labeling field 21-3, for example for specifying a shelf life, can also be provided on the rear side.

Figure 2G shows the tablet dispenser with the same reference numerals for the same parts as a hanging tablet dispenser in a perspective view from the side. This way of attachment is of particular advantage, as this is a one-handed operation by the user is possible. The user can pull the carrier element 21 out of the base element 20 with one hand and guide the medicament M to the mouth and take it in one-handed manner. A further advantage is that after the topmost support element 21 has been removed, inevitably the underlying underlying next support member 21 is visible with its drug M. FIG. 2H shows the carrier element 21, the base element 22 below the suspension element 23 with the same reference numbers on the left in a schematic front view and on the right in a schematic rear view.

FIG. 21 shows, in each case, in individual illustrations, with reference to the arrow, how the carrier element 21 designed as a spoon is pulled out of the film-like tube of the base element 20. The user grasps the handle 21-1, thereby exposing the spoon with the medicament M shown in FIG. 2J. As Figure 2K shows in the side-by-side illustrations, the occupant brings the spoon to the mouth, guides the endpiece 22-2 into the mouth, and releases the drug M, which engages the human-safe adhesive K on the endpiece 22-2 is fixed off with the lips and / or the tongue. The drug M, in particular the tablet can thus be safely led to the mouth and taken especially hygienic or administered, since the drug M does not come into contact with other objects. With the aid of the closure and hanging element 204 of the second outer packaging 200 or the hanging element 23 of the second packaging, the medicament M can always be attached visibly and presently. It is proposed to use this type of packaging and the associated second outer packaging 200, in particular for antibiotics of acutely ill persons, who must regularly take medication over a short period. In particular, it is very well suited as a packaging for a 6-day antibiotic. Other uses are also conceivable.

Third embodiment, the so-called "fixed powder" or the so-called "fixed ointment" on a so-called application rod or application stick with an associated outer packaging.

The package in the third embodiment is particularly suitable for applying ointments or powders. For the treatment with ointments, for example for the treatment of cold sores mostly tubes are sold and used. Usually, a treatment is necessary, which requires repeated daily application of the ointment. An application that is to be performed on the road, for example, is disadvantageous because then usually no clean hands are available. An additional infection of the diseased site is the result. In addition, the tubes, usually flexible aluminum tubes, with frequent kinking of the surface by the application and when taking the tube through the transport prone to damage.

An improved use of an ointment or a powder is given by the packaging in the third embodiment. FIG. 3A shows (left-hand illustration) a third packaging in an external perspective view from above and (left-hand illustration) in a perspective exterior view from below. As shown in the perspective interior view of Figure 3B, the third package on a third base member 30 which is designed as a bag, in particular a film pocket 32 which is disposed on a bottom and / or cover flap 36, 38 a folder. In this pocket, a third support member 31 can be plugged, wherein the drug M is fixed on a one-sided cushion 31-2, designed as a rod-shaped or spade-shaped element support member 31. The third support element 31 is thus a rod or a spatula which is inserted in the pocket of the third packaging. The film pocket 32 is at its upper edge with the bottom and / or Cover flap 36, 38 sealed, for example, welded or glued, wherein the seal is designed so that the support member 31, for the permanent protection of the drug M, embraced by the upper edge of the film pocket 32 above the end cushion 31-2 of the support member 31 and airtight is sealed. As FIG. 3B already shows, a plurality of film pockets 32 are arranged alternately on the inside of the third package in which the carrier elements 31 carrying the medicament M are mutually inserted. As a result, sufficient space is created between the carrier elements 31 for removing one of the carrier elements 31.

The third package has, analogously to the other two packages, a closure and hanging element 33, which is embodied in a cover element 34. The lid member 34 is followed by a front flap 35, which merges into the bottom flap 36 of the third package. The bottom flap 36 is followed by a rear flap 37, which merges into the cover flap 38. Bottom flap 36 under cover flap 38 each have a fold 36-1, 38-1, by means of which the bottom flap 36 and / or the cover flap 38 to facilitate the removal of the support member 31 is foldable. If the carrier element 31 is pulled out of the third base element 30, the foil pocket 32 arranged on the inner flap 36 and / or cover flap 38, it serves as an administration or administration element for the ointment. The rod or the spatula forms a grip 31-1 as the holding region and an end 31-2 as the application region, as shown in particular in FIG. 3C in a schematic representation. The end piece 31-2 is preferably a kind of cushion, in which the drug M is contained with its respective active ingredient. At the opposite end of the support member 31, a labeling field 31-3 can be specified with the name of the drug M, so that even when the support member 31 is separated from the third package, no confusion is possible.

Figure 3C shows a summary of a schematic representation of the third package. On the left side, the application is shown schematically by means of the support member 31. Right, the third packaging is shown in the closed state, with a labeling field 38-2 is provided at least on one side or even on two sides. The third package can be opened via the closure and hanging element 33 by pulling out a tab of the closure and hanging element 33 from a slot 39 arranged in the cover flap 38. In the unfolded state, which is shown in Figure 3C on the right side with the same reference numerals for the same components, the third package can be attached by means of the closure and hanging element 33 in the open state on a wall or the like. As a result, the support member 31 can be easily removed with one hand.

In connection with the schematic illustration (left) of FIG. 3C, which shows the application of an ointment, for example against cold sores, to the lips of a mouth, FIG. 3D shows a sequence of images showing the removal of the carrier element 31 designed as a rod or spatula ,

The handling of the third package is also intuitive, simple and hygienic since the drug M does not come into contact with other items. The user opens the third package, fanning the lid flap 38 and kinks the bottom flap 36 and / or the lid flap 38 in the region of the folds 36-1 and 38-1, whereby the grips 31-1 of the support members 31 are exposed and by their mutual Arrangement have large and comfortable removal distance to each other. The removal takes place by folding up the support member 31 relative to the bottom and / or cover flap 36, 38, whereby the support member 31 is broken out of the sealed film pocket 32, as in such a folding or pulling up of the support member 31, lying around the support member 31 Foil seal from the bottom and / or top flap 36, 38 stops and thereby peels off. Such a separately packaged support member 31 in such a third package can be easily removed, even from the elderly with little effort. The drug M located on the pad of the tail 31-2 can be applied to the infected site in a targeted manner. An exact dosage is possible, wherein the support member 31 is also provided for disposable use, whereby in particular a particularly hygienic application of the ointment is possible. A contact of the ointment with the finger to apply the ointment is therefore no longer necessary. Easier adherence to hygiene conditions shortens the healing process. The small and handy packaging as well as several arranged in a third outer packaging 300 packaging, allow the entrainment of Medication M also on the way, so that a discrete treatment of the diseased site is possible on the road.

Of particular advantage is also that by the one possible mechanical application of the drug M on the pillow 31-2 of the support member 31 is an exact dosage. It is also achieved that no unused, because no longer attainable residual amount of ointment remains in a package, as is the case with the known tubes.

This packaging of the third embodiment with the associated third outer packaging 300 is, as already mentioned, intended for the treatment of cold sores but also, for example, for the treatment of athlete's foot. Further uses are conceivable. For a multiple application per day, a folding folder ranges for example for two days, with a banderole-like container 302 of the third outer package 300 is designed for example for three such folders, which extends the possible application time accordingly.

FIG. 3E shows the third outer packaging 300 belonging to the third packaging, which is designed as a banderole-like container 302. This container 302 preferably has a labeling field 302-1 on at least one or more sides.

LIST OF REFERENCE NUMBERS

100 first outer packaging

101 cover flap

102 frame-like container

103 front lid flap

104 closure and hanging element

105 rear flap

106 bottom flap

107 front flap

107-1 Labeling field

108 inner flap

109 leaflet

1 10 slot first base element (blister) of the first packaging first, upper packaging (first blister)

first, lower packaging (second blister)

Carrier element (double-layered film)

first, outer carrier layer

second, inner carrier layer

fold

Labeling field second outer packaging

flap

prismatic container

Closure and hanging element

slot

Fold second base element (tube) of the second package

Carrier element (spoon)

grip 21-2 tail

21-3 labeling field

22 film tube

23 hanging element

300 third outer packaging

302 banderole-type container

302-1 labeling field

30 third base element (pocket) of the third package

31 support element (spatula, rod with cushion)

31-1 handle piece

31-2 tail (cushion)

31-3 labeling field

32 foil bag

33 hanging element

34 cover element

35 front flap

36 bottom flap

36-1 fold

37 rear flap

38 cover flap

38-1 fold

38-2 labeling field

39 slot M drug

K glue

Claims

Packaging for a medicament (M) comprising a base element (10, 20, 30) which protects the medicament (M) from external influences in the unopened state of the packaging, characterized in that the base element (10, 20, 30) is at least a support member (11, 21, 31) carrying the medicament (M) separable from the base member (10, 20, 30) of the package, whereby the support member (11, 21, 31) serves as a receiving or administering member for the drug (M) is used.

Packaging according to claim 1, characterized in that a first base element (10) is a blister whose at least one trough is closed with a carrier element (1 1), wherein the carrier element (1 1) has two layers and a first, outer carrier layer (1 1-1) and a second, inner carrier layer (1-2), wherein the medicament (M) on the inside of the second, inner carrier layer (1-2) directed towards the trough of the first base element (10) by means of a Adhesive (K) is fixed.

Packaging according to claim 1, characterized in that the second, inner carrier layer (1-2) in the closed state of the trough as a closure element on the edge of the trough is airtight and the first, outer carrier layer (1-1 1-1) by forming a Fold (1-3) substantially parallel to the second carrier layer (1-2) is arranged exposed as a tab-like opening element of the trough.

Packaging according to claim 2 or 3, characterized in that the first two-layer carrier element (1 1) in the withdrawn from the first base member (10) state as ingestion or administration element for the drug (M) a spoon with a through the first carrier layer (1 -1) forming a holding region formed by the second carrier layer (1 1-2) and application region.

Packaging according to claim 2 to 4, characterized in that the carrier layers (1 1-1, 1-2) of the carrier element (1 1) consist of a film, in particular a transparent film. Packaging according to at least one of claims 2 to 5, characterized in that the upper side of at least one carrier layer (11 -1, 1 1-2) serves as a labeling field (1 1-4).

Packaging according to claim 1, characterized in that a second base element (20) is a hose, in which at one end a carrier element (21) pluggable and the tube is closed airtight at both ends, wherein the drug (M) on the support element (21) by means of an adhesive (K) is fixed.

Packaging according to claim 7, characterized in that the second carrier element (21) in the state pulled out of the second base element (20), as the administration or administration element for the medicament (M), forms a spoon which forms a handle (21-1). having as a holding area and an end piece (21-2) as the application area.

Packaging according to claim 7, characterized in that in the second base element (20) formed at the other end of the support element (21) a suspension element (23) can be plugged.

0. Packaging according to claim 7 to 9, characterized in that the tube formed as a base element (20) consists of a film, in particular of a transparent film.

1. Packaging according to claim 8, characterized in that the handle (21 -1) on one or both sides as a labeling field (21-3) of the carrier element (21) is used.

2. Packaging according to claim 1, characterized in that a third base element

(30) is a pocket, which is arranged on a bottom and / or cover flap (36, 38) of a folding folder into which the carrier element (31) is pluggable, wherein the medicament (M) on a single-sided cushion (31-2 ) as a carrier element

(31) formed rod-shaped element, in particular a rod or spatula is fixed.

A package according to claim 12, characterized in that the carrier element (31) is in the state withdrawn from the second base element (30), as a delivery-related administration element for the medicament (M), a rod or forms a spatula having a handle (31-1) as a holding area and an end piece (31-2) as the application area.

14. Packaging according to claim 12 to 13, characterized in that the pocket formed as a base element (30) consists of a film, in particular of a transparent film.

15. Packaging according to claim 14, characterized in that the handle (31 -1) on one or both sides as a labeling field (31-3) of the carrier element (31) is used. 16. outer package (100), characterized in that the at least one first base element (10) with the carrier element (1 1) - a first package according to at least one of claims 1 to 6 - in a frame-like container (102) of a folding box (101 , 102, 103, 104, 105, 106, 107).

17. outer packaging (200), characterized in that the at least one second base element (20) with the carrier element (21) - a second packaging according to at least one of claims 1 and 7 to 1 1- in a prismatoid container (201, 202) is arranged.

18. outer package (300), characterized in that the at least one third base element (30) with the carrier element (31) - a third package according to at least one of claims 1 and 12 to 15 - in a banderoleartigen container (302) is arranged.